oral glp-1 for weight loss Patients taking an experimental drug lost significant and improved heart and metabolic risk factors in a large, worldwide phase 3 clinical trial led by Weill Cornell Medicine and other Clinically backed oral GLP Oral GLP-1 medication, brought to

"The most strange thing is that it feels really good to stretch, like when you first wake up," he wrote

Clinically defined by excessive hepatic lipid accumulation in the absence of excessive alcohol intake or other secondary causes of liver injury, NAFLD exhibits a strong bidirectional association with metabolic syndrome: up to 75% of adults with cardiometabolic conditions (e.g., obesity, T2DM, dyslipidemia) develop NAFLD, while NAFLD itself exacerbates systemic metabolic dysfunction (Steinberg et al., 2025)

Type 2 diabetes and cardiac autonomic neuropathy screening using dynamic pupillometry

What this article covers: What Are GLP-1 Drugs

Ramrez-Garza, S